Latham Advises Enovis on Binding Offer to Acquire eCential Robotics

Latham & Watkins is advising Enovis, an innovation-driven medical technology company, on its binding offer to acquire eCential Robotics, a leading developer of enabling technologies and surgical robotics. Under the terms of the agreement, Enovis will acquire eCential Robotics for an upfront enterprise value of €155 million and contingent consideration payable upon the achievement of certain milestones. The transaction is expected to close by year-end 2026, subject to regulatory approvals.

The Latham team is led by Paris and Chicago corporate partners Alexander Crosthwaite and Christopher Drewry, with Paris associates Jacek Urban, Cheryl Yviquel, and Pauline Sassard. Advice was also provided on healthcare and life sciences regulatory matters by Washington, D.C. partner Nathan Beaton, with Paris associate Jeanne Fabre; on securities law matters by Chicago partner Cathy Birkeland; on public law matters by Paris counsel Clément Fricaudet; on FDI matters by Paris associate Alexandre de Puysegur; on IP and commercial contracts matters by Paris partner Jean-Luc Juhan, with associate Claire-Emeline Auduc; on tax matters by Paris partner Estelle Philippi; on employment matters by Paris partner Matthias Rubner, with associate Alice Brisset; and on compliance matters by Paris associate Hana Ladhari.